Literature DB >> 2364995

Modulation of morphine antinociception by peripheral [Leu5]enkephalin: a synergistic interaction.

F Porreca1, Q Jiang, R J Tallarida.   

Abstract

This study determined whether the modulation of morphine antinociception by [Leu5]enkephalin, a compound which does not produce detectable antinociception when given i.p., was additive or synergistic. Co-administration of graded i.p. doses of morphine and [Leu5]enkephalin 20 min before testing resulted in a progressive leftward and parallel displacement of the i.p. morphine dose-response line. The increase in potency produced by i.p. [Leu5]enkephalin, but not the antinociception of i.p. morphine alone, was blocked by i.c.v. ICI 174,864. The data demonstrate strong and dose-related synergism between the two compounds, supporting the view that (a) peripheral administration of [Leu5]enkephalin can modulate morphine antinociception, apparently at the level of the brain and (b) that the interaction between mu and delta opioid agonists is not the result of simple additive action at the same (i.e., mu) receptor. Further evidence is thus provided for the existence of functional mu-delta interactions.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2364995     DOI: 10.1016/0014-2999(90)90190-h

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  26 in total

1.  Commentary on neostigmine interactions with non steroidal anti-inflammatory drugs by Miranda et al.

Authors:  Ronald J Tallarida
Journal:  Br J Pharmacol       Date:  2002-04       Impact factor: 8.739

Review 2.  Revisiting the isobole and related quantitative methods for assessing drug synergism.

Authors:  Ronald J Tallarida
Journal:  J Pharmacol Exp Ther       Date:  2012-04-17       Impact factor: 4.030

3.  Quantitative methods for assessing drug synergism.

Authors:  Ronald J Tallarida
Journal:  Genes Cancer       Date:  2011-11

4.  Biphasic characteristic of interactions between stiripentol and carbamazepine in the mouse maximal electroshock-induced seizure model: a three-dimensional isobolographic analysis.

Authors:  Jarogniew J Luszczki; Stanislaw J Czuczwar
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-09-14       Impact factor: 3.000

5.  Combinations of intrathecal gamma-amino-butyrate receptor agonists and N-methyl-d-aspartate receptor antagonists in rats with neuropathic spinal cord injury pain.

Authors:  Aldric Hama; Jacqueline Sagen
Journal:  Eur J Pharmacol       Date:  2012-03-16       Impact factor: 4.432

6.  Delta/mu opioid receptor interactions in operant conditioning assays of pain-depressed responding and drug-induced rate suppression: assessment of therapeutic index in male Sprague Dawley rats.

Authors:  Katherine Cone; Janell Lanpher; Abigail Kinens; Philomena Richard; Sarah Couture; Rebecca Brackin; Emily Payne; Kylee Harrington; Kenner C Rice; Glenn W Stevenson
Journal:  Psychopharmacology (Berl)       Date:  2018-03-23       Impact factor: 4.530

7.  Isobolographic characterisation of interactions among selected newer antiepileptic drugs in the mouse pentylenetetrazole-induced seizure model.

Authors:  Jarogniew J Luszczki; Stanislaw J Czuczwar
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-08-23       Impact factor: 3.000

8.  Increased Antiseizure Effectiveness with Tiagabine Combined with Sodium Channel Antagonists in Mice Exposed to Hyperbaric Oxygen.

Authors:  Ivan T Demchenko; Sergei Yu Zhilyaev; Olga S Alekseeva; Alexander I Krivchenko; Claude A Piantadosi; Heath G Gasier
Journal:  Neurotox Res       Date:  2019-05-30       Impact factor: 3.911

9.  Interactions of tiagabine with ethosuximide in the mouse pentylenetetrazole-induced seizure model: an isobolographic analysis for non-parallel dose-response relationship curves.

Authors:  Jarogniew J Luszczki
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-06-20       Impact factor: 3.000

10.  Mexiletine and its Interactions with Classical Antiepileptic Drugs: An Isobolographic Analysis.

Authors:  Kinga K Borowicz-Reutt; Monika Banach; Barbara Piskorska
Journal:  Neurochem Res       Date:  2016-01-06       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.